Articles: 27.11 November 2016

Full Content PDFs

Click here to find links to all the PDF articles from this issue of Prescriber

More details...

Recent advances in the management of cystic fibrosis

More effective management programmes and treatments mean that life expectancy for people with cystic fibrosis is improving. This article examines the expanding role of primary care in the management of cystic fibrosis and discusses the availability of new treatments that target the underlying cause of …

More details...

Sacubitril/valsartan for chronic heart failure its future potential

Sacubitril/valsartan (Entresto), a combined neprilysin inhibitor/angiotensin II-receptor antagonist for the treatment of chronic heart failure with reduced ejection fraction, was launched in the UK in January. The phase 3 clinical trial PARADIGM-HF established its efficacy in chronic heart failure but what is its future place …

More details...

Optimising care for people with motor neurone disease

The prospects for patients with a diagnosis of motor neurone disease are bleak; the disease progresses rapidly, life expectancy is low and there is currently no cure. However, recent initiatives are helping to improve patients’ quality of life through earlier diagnosis and optimising care.
Patients with …

More details...

Web design and marketing agency Leamington Spa